Choose Diag’s NIPT - Your Baby’s Health, Your Peace of Mind

NIPT test package
  • Shield IconScreen for 100+ chromosomal abnormalities like Down, Edwards, Patau syndromes & more
  • Shield IconHighly accurate - up to 99.9%
  • Shield Icon100% safe for both mother and fetus
  • Shield IconEarly testing - from the 10th week
  • Shield IconFast results - after 7 days
  • Shield IconNon-invasive, quick and painless
NIPT test package

NIPT (Non-Invasive Prenatal Testing) is a highly accurate screening test that analyzes cell-free fetal DNA (cff-DNA) derived from the placenta and circulating in the maternal blood to assess the risk of certain chromosomal abnormalities in the fetus.

This method is highly recommended by medical experts for its effectiveness in screening chromosomal abnormalities as early as the 10th week of gestation ensuring absolute safety for both the mother and the fetus.

NIPT offers an accuracy rate of up to 99.9%, providing comprehensive screening for over 100 genetic conditions related to chromosomal abnormalities, including aneuploidies and selected microdeletions/microduplications, across all 23 chromosome pairs.

Diag NIPT panels screen for:
- Three common Trisomy syndromes: Trisomy 21 (Down Syndrome), Trisomy 18 (Edwards Syndrome), and Trisomy 13 (Patau Syndrome).
- Four sex chromosome aneuploidies: Turner Syndrome (XO), Triple X Syndrome (XXX), Klinefelter Syndrome (XXY), and Jacob's Syndrome (XYY).
- Other autosomal aneuploidies.
- Microdeletions/Microduplications (92 Types).

Diag NIPT utilizes the DNBSEQ™ sequencing technology, which combines the advantages from low amplification error rates from DNA nanoballs (DNBs) and high-density patterned arrays. These advantages dramatically improve the sequencing accuracy.

NIPT is a screening test, not a diagnostic test. In cases of high-risk NIPT results, post-test genetic counseling is advised, and confirmatory diagnostic testing is recommended.

  • Pregnant women of any age (especially those aged 35 and above)

  • Pregnant women at increased risk for chromosomal abnormalities

  • Pregnant women with a history of recurrent miscarriage, stillbirth, or preterm labor

  • Pregnant women with a history of fetal delivery with chromosomal abnormalities

  • Pregnant women with a family history of chromosomal abnormalities

  • Contraindications for invasive prenatal testing (e.g., threatened abortion, tendency of bleeding, fever, chronic active infection …etc.)

  • Pregnant women with abnormal ultrasound

  • Pregnant women with high-risk value in the traditional biochemical-based screening methods (e.g., Double Test, Triple Test)

  • Pregnant women who have missed the best time for the traditional biochemical-based screening methods (e.g., Double and Triple tests)

  • Pregnant women working in hazards environments with exposure to chemicals

  • Pregnant women with singleton or twin pregnancies

  • Pregnancy following IVF or IUI

Our Packages

Instant Health Advice, Complete Privacy

Online Consultancy
Instant health advice and booking via Zalo or Facebook
advice-privacy
Full Privacy – Private Results
Your results and information remain strictly confidential
advice-privacy

Diag Is Always Near You

location-1
Over 40+ locations throughout Ho Chi Minh City
location-2

Blood Tests at Home – Easy & Comfortable

50,000+
Patients served at home
95%
Repeat customers
hbc

Frequently Asked Questions

Expectant mothers who have undergone a blood transfusion or organ transplant - NIPT can be performed at least 4 weeks after the procedure to ensure accurate results.

Pregnancies affted by Vanishing Twin Syndrome - NIPT can be used if both of the following conditions are met:
(1)The vanishing twin phenomenon occurred 8 weeks of pregnancy or earlier.
(2)There is a gap of at least 8 weeks between the vanishing twin event and the NIPT test.

If you are in cases where invasive prenatal screening is contraindicated, you should not do the NIPT test, including threatened abortion, tendency of bleeding, fever, chronic active infection, etc.

Experts recommend pregnant women undergo NIPT. However, mothers should consider 4 following factors:

- 100% safe: NIPT is asbolutely safe for both the mother and the fetus. Unlike amniocentesis, NIPT does not pose risks such as miscarriage, stillbirth, preterm birth, vaginal bleeding, or infection.

- Highly accurate: NIPT has high accuracy up to 99.9% but is only a screening test. However, as it is a screening test, confirmatory diagnosis through amniocentesis is necessary if a high risk of abnormalities is detected.

- Fast results: NIPT results are available within 5 working days, whereas amniocentesis takes 10 to 14 days.

- Cost-effective: Diag’s NIPT Panels range from 1,500,000 to 7,500,000 VND, whereas amniocentesis costs 10,000,000 VND or more.

NIPT helps identify the majority of congenital abnormalities, including:

- Trisomies: Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), Patau syndrome (Trisomy 13), Trisomy 22, Trisomy 16, Trisomy 9.

- Sex chromosome aneuploidies: Klinefelter syndrome (XXY), Turner syndrome (Monosomy X), Jacobs syndrome (XYY), Triple X syndrome.

- Deletion/Duplication syndromes: Prader-Willi/Angelman syndrome, DiGeorge syndrome, Jacobsen syndrome, Cat Eye syndrome, Cri-du-chat syndrome, etc.

A "negative" or "no abnormality detected" result indicates a very low risk of the fetus having genetic disorders. However, low risk does not guarantee the fetus will be free of congenital disorders. Therefore, regular prenatal check-ups and tests as directed by obstetricians are necessary.

Pregnant women need to bring their most recent ultrasound results to Diag for consultation before the test. There are no specific timing requirements for NIPT.

Double Test and Triple Test are suitable alternatives in case NIPT is not required or affordable. Diag offers fetal defect screening services at the following prices:

- Double Test: 384,000 VND

- Triple Test: 450,000 VND

Whole Genome Sequencing (WGS) is the technology used to analyze the entire cell‐free fetal DNA (cffDNA) present in the mother's blood. This method allows the detection of a wide range of genetic abnormalities, from major chromosomal abnormalities (such as trisomies) to smaller variations like deletions and duplications.

WGS utilizes the fetal fraction DNA enrichment process (FF%) to increase the concentration of cffDNA. It combines selective DNA fragment processing with advanced bioinformatics analysis and cutting-edge DNBSEQ™ technology. This process significantly reduces repeat testing rates, minimizes errors and enhances the detection of complex genetic variations, such as those seen in DiGeorge syndrome.

The NIPT test can be performed as early as the 10th week of pregnancy, allowing for early detection of potential chromosomal abnormalities.

If your NIPT results indicate a high risk of chromosomal abnormalities, obstetricians will discuss further diagnostic options, such as amniocentesis to confirm the results.

NIPT works by analyzing cell-free fetal DNA found in the mother's blood. This DNA is screened for chromosomal abnormalities that can indicate genetic disorders.

The DIAG's NIPT Pro is optimized to offer the most cost-effective solution. It provides a comprehensive screening for more than 100 congenital abnormalities, surpassing other prenatal screening methods such as Double Test, Triple Test, and older NIPT technologies.

By combining advanced Whole Genome Sequencing (WGS) and DNBSEQ™ technology, NIPT Pro ensures higher accuracy, better detection rates and reduced the need for repeat testing, making it a superior choice for early and safe prenatal screening.

If DIAG's lab receives the sample before 10:00 AM (Mon & Thu), test results will be available by 10:00 AM four days later.
If DIAG's lab receives the sample after 10:00 AM (Mon - Thu), test results will be available by 10:00 AM seven days later.

Book Test  width= Zalo Button Messenger Button promotion